Back to results

Seton Hall University

Testing the efficacy of LSN2463359, a metabotropic glutamate 5 receptor positive allosteric modulator, in animal models of schizophrenia

Abstract

dc:description.abstract

<p>For many years the dominant theory surrounding the cause of schizophrenia was focused on elevated dopamine levels found in critical areas of the brain. Recently a new theory has emerged pointing to elevated glutamate levels resulting from hypofunction of NMDA receptors and hypoactivity of GABAergic neurons which normally inhibit glutamatergic cells in a tonic manner. Therefore, while traditional antipsychotics directly block dopamine receptors, some of the newly generated compounds are designed to modulate glutamate to normal levels.</p> <p><strong></strong>I propose testing the efficacy of the metabotropic glutamate 5 receptor modulator LSN2463359, previously shown to act as an indirect agonist of the NMDA receptor, in two different animal models of schizophrenia. Our study found that when LSN2463359 was administered to rats given SDZ 220-581 (an NMDA antagonist) levels of GABA, glutamate, dopamine and NAA (a marker for cell health) were modulated to normal levels. Furthermore, when the compound was administered to neuregulin-1 knockout mice, behaviors related to anxiety and social activity were also modulated to normal levels. Developing novel therapies targeting a different pathway involved with psychosis may help reduce side effects and may be beneficial in relieving symptoms not currently well treated by traditional antipsychotics.</p>

Degree

thesis:*
Name thesis:degree_name
MS Biology
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Biology
Year dc:date.available
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Freamon, Dierdre M.
Contributors dc:contributor
  • Sylvia A. Rabacchi, Ph.D
  • Edward G. Tall, Ph.D
  • Agela V. Klaus, Ph.D

Subjects

dc:subject × 8

Identifiers

dc:identifier.*
Repository record dc:identifier
https://scholarship.shu.edu/dissertations/2130
OAI identifier oai:identifier
oai:scholarship.shu.edu:dissertations-3177

Chain of custody

source
Harvested from
Seton Hall University
Base URL
scholarship.shu.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Freamon, Dierdre M.. Testing the efficacy of LSN2463359, a metabotropic glutamate 5 receptor positive allosteric modulator, in animal models of schizophrenia. Thesis thesis, 2015. https://scholarship.shu.edu/dissertations/2130